Literature DB >> 16019469

Arsenic trioxide: an anti cancer missile with multiple warheads.

Yair Gazitt1, Cagla Akay.   

Abstract

The proven efficacy of ATO in the treatment of APL and the emerging importance of ATO in other diseases prompted extensive studies of the mechanisms of action of ATO in APL and in other types of cancers. In this review we will focus on downstream events in ATO-induced intrinsic and extrinsic apoptotic pathways with an emphasis on the role of pro-apoptotic and anti-apoptotic proteins and the role of p53 in ATO-induced apoptosis including its effect on cell cycle, its anti-mitotic effect and the role of apoptosis inducing factors (AIF) in ATO-induced apoptosis, chromatin condensation and nuclear fragmentation in myeloma cells as a model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019469     DOI: 10.1080/10245330500067090

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  14 in total

1.  Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.

Authors:  Majid Zaki Dizaji; Mohsen Malehmir; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Seyed H Ghaffari
Journal:  Neurochem Res       Date:  2011-10-04       Impact factor: 3.996

2.  Epoxyeicosatrienoic acids attenuate reactive oxygen species level, mitochondrial dysfunction, caspase activation, and apoptosis in carcinoma cells treated with arsenic trioxide.

Authors:  Liu Liu; Chen Chen; Wei Gong; Yuanjing Li; Matthew L Edin; Darryl C Zeldin; Dao Wen Wang
Journal:  J Pharmacol Exp Ther       Date:  2011-08-16       Impact factor: 4.030

3.  Arsenic trioxide inhibits cholangiocarcinoma cell growth and induces apoptosis.

Authors:  Fei Zhong; Shineng Zhang; Chunkui Shao; Jing Yang; Xiangyuan Wu
Journal:  Pathol Oncol Res       Date:  2009-12-12       Impact factor: 3.201

4.  The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in SGC7901 human gastric cancer cells.

Authors:  Yihu Zheng; Mengtao Zhou; Aifang Ye; Qiu Li; Yongheng Bai; Qiyu Zhang
Journal:  World J Surg Oncol       Date:  2010-04-20       Impact factor: 2.754

5.  Upregulation and maintenance of gap junctional communication in lens cells.

Authors:  Bruce A Boswell; Anh-Chi N Le; Linda S Musil
Journal:  Exp Eye Res       Date:  2008-12-11       Impact factor: 3.467

6.  Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.

Authors:  Jun Lu; Eng-Hui Chew; Arne Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

7.  Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction.

Authors:  Ye Cheng; Yunqian Li; Chengyuan Ma; Yang Song; Haiyang Xu; Hongquan Yu; Songbai Xu; Qingchun Mu; Haisong Li; Yong Chen; Gang Zhao
Journal:  Oncotarget       Date:  2016-03-15

8.  BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells.

Authors:  Songmin Ying; Katie Myers; Sarah Bottomley; Thomas Helleday; Helen E Bryant
Journal:  Nucleic Acids Res       Date:  2009-06-23       Impact factor: 16.971

9.  Neuroblastoma cell death is induced by inorganic arsenic trioxide (As(2)O(3)) and inhibited by a normal human bone marrow cell-derived factor.

Authors:  Benjamin Gesundheit; Lea Malach; Reuven Or; Talia Hahn
Journal:  Cancer Microenviron       Date:  2008-08-27

10.  Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis.

Authors:  Yong Zhang; Xianxian Wu; Yang Li; Haiying Zhang; Zhange Li; Ying Zhang; Longyin Zhang; Jiaming Ju; Xin Liu; Xiaohui Chen; Peter V Glybochko; Vladimir Nikolenko; Philipp Kopylov; Chaoqian Xu; Baofeng Yang
Journal:  Sci Rep       Date:  2016-09-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.